2-(5-Chloro-2-hydroxy-phenyl)-5-(3-chloro-4-trifluoromethyl-phenyl)-2,4-dihydro-[1,2,4]triazol-3-one

ID: ALA13755

PubChem CID: 135830836

Max Phase: Preclinical

Molecular Formula: C15H8Cl2F3N3O2

Molecular Weight: 390.15

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Oc1ccc(Cl)cc1-n1nc(-c2ccc(C(F)(F)F)c(Cl)c2)nc1O

Standard InChI:  InChI=1S/C15H8Cl2F3N3O2/c16-8-2-4-12(24)11(6-8)23-14(25)21-13(22-23)7-1-3-9(10(17)5-7)15(18,19)20/h1-6,24H,(H,21,22,25)

Standard InChI Key:  LPLFGQAKNUMAQT-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    2.6792   -1.5750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8667   -1.4042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0917   -0.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5375   -0.2417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7875   -0.5875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0167   -2.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3583    0.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0708    1.0708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3542    1.0708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0667   -0.1750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5292   -2.9917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3583   -0.1750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0667    0.6583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8292   -2.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9042   -0.7667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3542   -0.5875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7208    1.4458    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2083    1.9208    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8708    0.7583    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.1667   -3.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8625   -3.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3500    1.8958    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.6875   -3.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3792   -4.4167    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.3125   -1.7375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  3  2  0
  5  2  2  0
  6  1  1  0
  7 12  2  0
  8  7  1  0
  9 13  2  0
 10  5  1  0
 11  6  2  0
 12 16  1  0
 13 10  1  0
 14  6  1  0
 15  3  1  0
 16 10  2  0
 17  8  1  0
 18  8  1  0
 19  8  1  0
 20 14  2  0
 21 11  1  0
 22  9  1  0
 23 20  1  0
 24 21  1  0
 25 14  1  0
  5  4  1  0
 23 21  2  0
  7  9  1  0
M  END

Alternative Forms

  1. Parent:

    ALA13755

    ---

Associated Targets(Human)

KCND3 Tclin Voltage-gated potassium channel subunit Kv4.3 (100 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 390.15Molecular Weight (Monoisotopic): 388.9946AlogP: 4.67#Rotatable Bonds: 2
Polar Surface Area: 71.17Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 5.99CX Basic pKa: CX LogP: 5.82CX LogD: 4.65
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.67Np Likeness Score: -1.26

References

1. Hewawasam P, Erway M, Thalody G, Weiner H, Boissard CG, Gribkoff VK, Meanwell NA, Lodge N, Starrett JE..  (2002)  The synthesis and structure-activity relationships of 1,3-diaryl 1,2,4-(4H)-triazol-5-ones: a new class of calcium-dependent, large conductance, potassium (maxi-K) channel opener targeted for urge urinary incontinence.,  12  (7): [PMID:11909730] [10.1016/s0960-894x(02)00099-9]

Source